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cell lung cancer，NSCLC）辐射抗性模型，通过 ChIP-Seq 基因组学分析发现，
NSCLC 获得辐射抗性后，基因组 H3K4 共价修饰发生了重分布，但是不同肺癌
细胞组蛋白甲基化重建状态有差异，在获得辐射抗性的 A549 细胞中基因组




角度进行了阐述， DNA 损伤修复的重要基因 SMARCA5 和 FANCI 在两种不同的
肺癌细胞中受到差异调控，在 A549 和 H1299 细胞中应用靶向 H3K4me3 抑制剂
处理也明显下调这两个基因的表达，说明 H3K4me3 通过调控 DNA 损伤修复基
因介导肺癌细胞辐射抗性耐受机制。然而，瞬时电离辐射刺激 NSCLC 可激活






















结合降低，抑制了 A549 细胞的 H3K4me3 修饰，进一步下调 DNA 损伤修复关键
基因表达，参与肺癌细胞辐射耐受机制的建立，不同肺癌细胞组蛋白重建规律有
差异。而在肺癌细胞瞬时辐射应激反应中，H3K4me3 被激活，抑制 H3K4me3 可
增强肺癌细胞辐射敏感性。同时，MEN1 在肿瘤外环境中抑制成纤维细胞向肌成





































Lung cancer is now the most common malignant that threatens human health 
worldwide. Radiotherapy is the mainstay of curative lung cancer treatments, but radio-
resistance and tumor relapse after radiotherapy seriously restricts the therapeutic effect. 
A large number of evidence show that the mechanism of radio-resistance to lung cancer 
cells can be attributed to genetic alteration. However, the gene network is intricate, and 
the effective target molecules and regulatory channels are still not clearly understood. 
In addition, the tumor microenvironment is also a significant factor that affects the 
radiation-resistance. The pathological changes occur both inside and outside the tumor 
at the same time eventually lead to tumor malignancy and radiation resistance. 
Therefore, it is necessary to investigate the synergistic mechanism of the environment 
inside and outside the tumor, and epigenetic alteration is a new direction to elucidate 
the mechanism. Histone modification is one of the epigenetic modifications, which can 
mediate the reprograming of chromatin structure and regulation of gene transcription, 
but its mechanism of radio-resistance in lung cancer and the pathological change in 
extracellular environment of lung cancer remains to be further explored. 
In this study, we established radio-resistant model of non-small cell lung cancer 
(NSCLC) by fractionated irradiation of X-rays (induced). ChIP-Seq genomics analysis 
showed that the reprogramming of genomic H3K4 covalent modification exists in 
NSCLC with acquired radio-resistance, but the methylation status varies in different 
lung cancer cells. The genotype H3K4me3 was inhibited in A549 cells with radio-
resistance, but no obvious change was observed in H1299 cells. The detection of 
H3K4me3-specific methyltransferase revealed that the binding of methyltransferase to 
chromatin in A549 cells decreased with the emergence of radio-resistance, that is, the 
decrease of histone methyltransferase mediated the decrease of H3K4me3. Significant 
changes were not detected in H1299 cells. Analysis of the target genes selected by 
ChIP-Seq showed that SMARCA5 and FANCI, which are important genes in DNA 

















treatment of with H3K4me3 inhibitor in A549 and H1299 cells also down-regulated the 
expression of these two genes.  
This result indicated that H3K4me3 promote radio-resistance of lung cancer cell 
by regulating the gene expression involved in DNA damage repair. Treatment of 
inhibitors can increase the radiosensitivity of lung cancer cells through reducing the 
level of H3K4me3. In the external environment of the tumor, the MEN1 gene inhibits 
the differentiation and activation of fibroblasts by inhibiting the expression of 
extracellular matrix, the expression of fibrosis factor and the chemotaxis of fibroblasts 
in fibroblasts. Moreover, MEN1 promotes epithelial-mesenchymal transition in 
epithelial cells.  Little is known about how H3K4 reprogramming regulates the 
activation and differentiation of fibroblast. 
This study found that fractionated radiation down-regulated the combination of 
histone methyltransferase complex with chromatin, which resulted in the chromatin 
remodeling in NSCLC. Furthermore, this reprogramming regulates the key gene 
expression involved in DNA damage repair and results in the radio-resistance in lung 
cancer cell. In addition, MEN1 in the tumor external environment inhibits the 
differentiation from fibroblasts to myofibroblasts and its activation, and promotes 
epithelial - mesenchymal transition. Menin encoded by MEN1 gene mediates 
H3K4me3 remodeling, which is also involved in the differentiation and activation of 
fibroblasts. This study investigated the epigenetic mechanism of radio-resistance of 
lung cancer and the function of MEN1 in the tumor external environment, which 
provided a new way to overcome the problem of raio-resistence. 
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MEK-ERK 通路和 PI3K-Akt 通路都被激活，但在 K-Ras G12S 突变的肺癌细胞
中，这两条信号通路更是被高度激活，且其高度激活对于辐射抗性的获得是很关

















2）和磷酸化 STAT3（Signal Transducer and Activator of Transcription 3）水平增高，
进一步上调 BcL2/BcL-XL 的水平。激活的 STAT3 被发现聚集在获得辐射抗性的
细胞核中。可见，激活 JAK2/STAT3/Bcl2/BcL-XL 通路也是获得辐射抗性的关键
机制。因此，STAT3 抑制剂氯硝柳胺可通过阻断 JAK2/STAT3/Bcl2/BcL-XL 通路
来增加肺癌细胞的敏感性[21]。另有很多关键基因对于肺癌细胞的辐射抗性产生
有很大意义。p53 可通过抑制细胞自噬，并激活细胞凋亡来调节肺癌细胞的辐射





DNA 损伤。DNA 损伤反应（DNA damage response, DDR）是指细胞受到内源性
或者外源性刺激后，细胞为维持基因组稳定性而发生的生物学反应[23]。DDR 涉
及到的通路有很多，包括与 DNA 双链断裂相关的同源重组（Homologous 
Recombination, HR）、非同源末端连接（Non‑homologous end joining, NHEJ）、
范科尼贫血症通路（Fanconi anaemia pathway, FA），以及与 DNA 单链断裂相关
的碱基切除修复（Base excision repair, BER）、错配修复（Mismatch repair, MMR）、
核苷酸切除修复（Nucleotide excision repair, NER）、直接修复（Direct repair, DR），
还有跨损伤修复（Translesion synthesis, TLS）[24]。对电离辐射诱导的 DNA 损伤
修复反应的研究无论是对癌症治疗还是预防电离辐射对于正常细胞的毒害作用
都有深远意义。在众多通路中所涉及到的一些关键基因在该反应中也发挥着很重
要的作用。FANCI（Fanconi anemia I protein）是范科尼贫血症通路中的一个关键
蛋白，它能泛素化 FA 通路的另一个关键蛋白 FANCD2，并被 FANCD2 泛素化，
组成 FANCI-FANCD2（ID）复合物，在 DNA 损伤发生时结合到染色体上，在损
伤修复、周期检验点控制以及细胞生存方面都起着重要作用[25]。有研究证明，ID
复合物的形成和维持是 FA 通路参与 DNA 损伤修复的关键[26]。有趣的是，FANCI
还有一些不依赖于 FANCD2 的功能，在 DNA 损伤发生时，FA 核心复合物在细
胞核中形成，并在细胞周期的 S 期和 G2 期被招募至损伤位点，参与损伤修复反
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